Production (Stage)
Context Therapeutics Inc.
CNTX
$0.6095
-$0.0199-3.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.58M | -3.34M | -17.46M | -2.25M | -3.67M |
| Total Depreciation and Amortization | 4.10K | 2.90K | 2.80K | 2.60K | 2.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 319.70K | 257.10K | 14.98M | 157.00K | 240.00K |
| Change in Net Operating Assets | -774.90K | -1.82M | 544.20K | -1.26M | -935.40K |
| Cash from Operations | -5.03M | -4.91M | -1.93M | -3.36M | -4.36M |
| Capital Expenditure | -33.90K | 0.00 | -7.30K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | -14.75M | -- | -- |
| Cash from Investing | -33.90K | 0.00 | -14.76M | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 14.54M | -- | 94.80M | -- |
| Repurchase of Common Stock | -- | -- | -44.60K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15.30K | -- | -- | -- | -- |
| Cash from Financing | -15.30K | 14.54M | -44.60K | 94.80M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.08M | 9.63M | -16.74M | 91.45M | -4.36M |